Medications

EU approves Sanofi drug for chronic lung disease

The European Union has approved Sanofi and Regeneron's blockbuster drug Dupixent for the treatment of chronic obstructive pulmonary disease (COPD), the French pharmaceutical giant said on Wednesday.

Medical research

New study finds systematic biases at play in clinical trials

Randomized controlled trials, or RCTs, are believed to be the best way to study the safety and efficacy of new treatments in clinical research. However, a recent study from Michigan State University found that people of color ...

Psychology & Psychiatry

Depression therapy has magnetic appeal across Minnesota

A magnetic therapy for persistent depression is in such demand in the Twin Cities that Allina Health has doubled its capacity with the opening of a new mental health center in Fridley, Minnesota.

Medications

Centering underrepresented populations in pharmacy research

Underrepresented populations have been historically excluded from clinical trials including women, racial and ethnic minority groups, and pregnant, lactating, pediatric and geriatric populations. While the importance of including ...

page 3 from 40